PMID- 23286698 OWN - NLM STAT- MEDLINE DCOM- 20130719 LR - 20211021 IS - 1471-4159 (Electronic) IS - 0022-3042 (Print) IS - 0022-3042 (Linking) VI - 125 IP - 5 DP - 2013 Jun TI - Characterization of electroencephalographic and biochemical responses at 5-HT promoting drug-induced onset of serotonin syndrome in rats. PG - 774-89 LID - 10.1111/jnc.12141 [doi] AB - Many psychotropic substances used either for medications or illicit recreational purposes are able to produce an increase in extracellular serotonin (5HT) in the CNS. 5HT is well known to improve mood; however, only when the levels of its release are in an appropriate range. Excessive 5HT is harmful, and will generally result in serotonin syndrome. To date, clinical diagnosis of serotonin syndrome relies exclusively on observation of symptoms because of a lack of available laboratory tests. The goal of this study was to characterize the onset of the syndrome using laboratory settings to determine excessive 5HT-evoked neurological abnormalities. Experiments were carried out in rats with the syndrome being elicited by three groups of 5HT-promoting drugs: (i) (+/-)-3,4-methylenedioxymethamphetamine (MDMA); (ii) a combination of the monoamine oxidase inhibitor clorgyline with the 5HT precursor 5-hydroxytryptophan; (iii) clorgyline combined with the serotonin-selective reuptake inhibitor paroxetine. The onset of the syndrome was characterized by electroencephalography (EEG), tremor, and brain/plasma 5HT tests. We found that a mild syndrome was associated with reduced EEG amplitudes while a severe syndrome strongly with seizure-like EEG activity and increased tremor activity. The occurrence of the syndrome was confirmed with microdialysis, showing excessive 5HT efflux in brain dialysate and the increased concentration of unbound 5HT in the plasma. Our findings suggest that the syndrome onset can be revealed with EEG recording, measurements of tremor activity and changes of unbound 5HT concentration in the plasma. CI - (c) 2013 International Society for Neurochemistry. FAU - Ma, Zhiyuan AU - Ma Z AD - Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida 33431, USA. FAU - Rudacille, Mary AU - Rudacille M FAU - Prentice, Howard M AU - Prentice HM FAU - Tao, Rui AU - Tao R LA - eng GR - R15 DA029863/DA/NIDA NIH HHS/United States GR - R15DA029863/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20130128 PL - England TA - J Neurochem JT - Journal of neurochemistry JID - 2985190R RN - 0 (Serotonin Agents) RN - 333DO1RDJY (Serotonin) SB - IM MH - Animals MH - Brain/drug effects/*metabolism MH - Brain Chemistry/drug effects/physiology MH - Electroencephalography/*drug effects/methods MH - Extracellular Fluid/drug effects/metabolism MH - Male MH - Rats MH - Rats, Sprague-Dawley MH - Serotonin/*metabolism MH - Serotonin Agents/*toxicity MH - Serotonin Syndrome/chemically induced/*metabolism/*physiopathology PMC - PMC4242192 MID - NIHMS432864 COIS- Conflicts of interest: The authors declare no conflicts of interest. EDAT- 2013/01/05 06:00 MHDA- 2013/07/20 06:00 PMCR- 2014/11/24 CRDT- 2013/01/05 06:00 PHST- 2012/07/24 00:00 [received] PHST- 2012/12/20 00:00 [revised] PHST- 2013/01/02 00:00 [accepted] PHST- 2013/01/05 06:00 [entrez] PHST- 2013/01/05 06:00 [pubmed] PHST- 2013/07/20 06:00 [medline] PHST- 2014/11/24 00:00 [pmc-release] AID - 10.1111/jnc.12141 [doi] PST - ppublish SO - J Neurochem. 2013 Jun;125(5):774-89. doi: 10.1111/jnc.12141. Epub 2013 Jan 28.